Childrens Hospital Orange County

Orange, California 92968

9 studies enrolling now · 31 studies all time

What they study most

ALL, ALL, Childhood, AML, Absence Epilepsy, Absence Seizures, Acute Myelogenous Leukemia, Acute Respiratory Distress Syndrome in Children, Acute Undifferentiated Leukemia, B-cell Acute Lymphoblastic Leukemia, BPDCN, Bladder and Bowel Dysfunction, Bronchiolitis Acute Viral

Studies at this site

• Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset — Recruiting now
• ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma — Recruiting now
• Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy — Recruiting now
• Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma — Recruiting now
• Pediatric Down Syndrome Post-Approval Study — Recruiting now
• Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies — Recruiting now
• Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL — Recruiting now
• Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence — Recruiting now
• HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors — Running, not enrolling
• Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D) — Running, not enrolling
• PROSpect: Prone and Oscillation Pediatric Clinical Trial — Running, not enrolling
• Peppermint Oil as a Treatment for Children With Bladder and Bowel Dysfunction — Enrolling by invitation
• Eliminating Monitor Overuse Trial (EMO Trial) — Running, not enrolling
• Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy — Completed
• Epigenetic Reprogramming in Relapse/Refractory AML — Completed
• Assessing Comorbidities in Epilepsy Using Eye Movement Recordings — Completed
• A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact — Completed
• Evaluation of the Duration of Therapy for Thrombosis in Children — Completed
• PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma — Completed
• Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes — Completed
• Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3) — Stopped early
• A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors — Completed
• Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology — Completed
• Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects — Stopped early
• A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma — Completed
• Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III) — Completed
• Detecting Absence Seizures Using Eye Tracking — Completed
• Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL — Stopped early
• TIME Study: Therapeutic Hypothermia for Infants With Mild Encephalopathy — Status unconfirmed
• A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT — Stopped early